Becky Kinkead

4.8k total citations
64 papers, 2.6k citations indexed

About

Becky Kinkead is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Becky Kinkead has authored 64 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cellular and Molecular Neuroscience, 24 papers in Molecular Biology and 13 papers in Reproductive Medicine. Recurrent topics in Becky Kinkead's work include Neuropeptides and Animal Physiology (25 papers), Receptor Mechanisms and Signaling (23 papers) and Hypothalamic control of reproductive hormones (13 papers). Becky Kinkead is often cited by papers focused on Neuropeptides and Animal Physiology (25 papers), Receptor Mechanisms and Signaling (23 papers) and Hypothalamic control of reproductive hormones (13 papers). Becky Kinkead collaborates with scholars based in United States, Germany and Italy. Becky Kinkead's co-authors include Charles B. Nemeroff, Michael J. Owens, Elisabeth B. Binder, Boadie W. Dunlop, Mark Hyman Rapaport, Pamela J. Schettler, Ricardo Cáceda, Helen S. Mayberg, David Mischoulon and Andrew A. Nierenberg and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Becky Kinkead

61 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Becky Kinkead United States 28 953 826 440 435 376 64 2.6k
Gábor Faludi Hungary 28 829 0.9× 762 0.9× 589 1.3× 711 1.6× 273 0.7× 87 2.7k
Bruce R. Lawford Australia 31 833 0.9× 784 0.9× 314 0.7× 329 0.8× 307 0.8× 76 2.6k
Fokko J. Bosker Netherlands 31 984 1.0× 608 0.7× 505 1.1× 640 1.5× 277 0.7× 82 2.6k
Xian‐Zhang Hu United States 21 1.2k 1.3× 531 0.6× 474 1.1× 410 0.9× 587 1.6× 43 3.2k
David Nutt United Kingdom 29 1.3k 1.4× 758 0.9× 256 0.6× 198 0.5× 480 1.3× 72 2.5k
Michiko Nakazato Japan 27 1.4k 1.4× 627 0.8× 339 0.8× 572 1.3× 883 2.3× 88 3.8k
Declan N.C. Jones United Kingdom 37 1.7k 1.8× 1.2k 1.5× 657 1.5× 637 1.5× 683 1.8× 64 3.4k
Pierre-Éric Lutz Canada 22 877 0.9× 759 0.9× 309 0.7× 261 0.6× 203 0.5× 47 2.0k
Richard De La Garza United States 39 2.0k 2.1× 777 0.9× 435 1.0× 581 1.3× 677 1.8× 143 4.1k
Irina Esterlis United States 30 1.0k 1.1× 761 0.9× 399 0.9× 816 1.9× 691 1.8× 101 3.0k

Countries citing papers authored by Becky Kinkead

Since Specialization
Citations

This map shows the geographic impact of Becky Kinkead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Becky Kinkead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Becky Kinkead more than expected).

Fields of papers citing papers by Becky Kinkead

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Becky Kinkead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Becky Kinkead. The network helps show where Becky Kinkead may publish in the future.

Co-authorship network of co-authors of Becky Kinkead

This figure shows the co-authorship network connecting the top 25 collaborators of Becky Kinkead. A scholar is included among the top collaborators of Becky Kinkead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Becky Kinkead. Becky Kinkead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamon‐Fava, Stefania, Minying Liu, Boadie W. Dunlop, et al.. (2023). Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators. Neuropsychopharmacology. 48(6). 929–935. 22 indexed citations
2.
Mischoulon, David, Boadie W. Dunlop, Becky Kinkead, et al.. (2022). Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation. The Journal of Clinical Psychiatry. 83(5). 41 indexed citations
3.
Lamon‐Fava, Stefania, Jisun So, David Mischoulon, et al.. (2020). Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins Leukotrienes and Essential Fatty Acids. 164. 102219–102219. 47 indexed citations
4.
Dunlop, Boadie W., Devon LoParo, Becky Kinkead, et al.. (2019). Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression. American Journal of Psychiatry. 176(4). 275–286. 38 indexed citations
5.
Loring, David W., Kimford J. Meador, Shlomo Shinnar, et al.. (2019). Differential antiseizure medication sensitivity of the Affective Reactivity Index: A randomized controlled trial in new-onset pediatric focal epilepsy. Epilepsy & Behavior. 102. 106687–106687.
6.
Kinkead, Becky, et al.. (2018). Model structure for protocol adherence utilizing a manualized therapeutic massage intervention. Journal of Complementary and Integrative Medicine. 16(2). 5 indexed citations
7.
Dunlop, Boadie W., Justin Rajendra, W. Edward Craighead, et al.. (2017). Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder. American Journal of Psychiatry. 174(6). 533–545. 209 indexed citations
8.
Dunlop, Boadie W., Mary E. Kelley, Tanja Mletzko, et al.. (2017). Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study. American Journal of Psychiatry. 174(6). 546–556. 94 indexed citations
9.
Rapaport, Mark Hyman, Andrew A. Nierenberg, Pamela J. Schettler, et al.. (2015). Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Molecular Psychiatry. 21(1). 71–79. 212 indexed citations
10.
Mischoulon, David, et al.. (2014). A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression. The Journal of Clinical Psychiatry. 76(1). 54–61. 58 indexed citations
11.
Rakofsky, Jeffrey J., Pamela J. Schettler, Becky Kinkead, et al.. (2013). The Prevalence and Severity of Depressive Symptoms Along the Spectrum of Unipolar Depressive Disorders. The Journal of Clinical Psychiatry. 74(11). 1084–1091. 13 indexed citations
12.
Dunlop, Boadie W., Elisabeth B. Binder, Joseph F. Cubells, et al.. (2012). Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials. 13(1). 106–106. 88 indexed citations
14.
Wilson, Michelle & Becky Kinkead. (2007). Gene-Environment Interactions, Not Neonatal Growth Hormone Deficiency, Time Puberty in Female Rhesus Monkeys1. Biology of Reproduction. 78(4). 736–743. 18 indexed citations
15.
Welberg, Leonie, Becky Kinkead, K. V. Thrivikraman, et al.. (2006). Ketamine-xylazine-acepromazine anesthesia and postoperative recovery in rats.. PubMed. 45(2). 13–20. 25 indexed citations
16.
Geracioti, Thomas D., Linda L. Carpenter, Michael J. Owens, et al.. (2006). Elevated Cerebrospinal Fluid Substance P Concentrations in Posttraumatic Stress Disorder and Major Depression. American Journal of Psychiatry. 163(4). 637–643. 83 indexed citations
17.
Garlow, Steven J., et al.. (2005). Genetic Analysis of the Hypothalamic Neurotensin System. Neuropsychopharmacology. 31(3). 535–543. 8 indexed citations
18.
Kinkead, Becky & Charles B. Nemeroff. (2004). Neurotensin, Schizophrenia, and Antipsychotic Drug Action. International review of neurobiology. 59. 327–349. 44 indexed citations
19.
Binder, Elisabeth B., Becky Kinkead, Michael J. Owens, & Charles B. Nemeroff. (2004). Neurotensin Receptor Antagonist SR 142948A Alters Fos Expression and Extrapyramidal Side Effect Profile of Typical and Atypical Antipsychotic Drugs. Neuropsychopharmacology. 29(12). 2200–2207. 19 indexed citations
20.
Kinkead, Becky. (2002). Neurotensin: an endogenous antipsychotic?. Current Opinion in Pharmacology. 2(1). 99–103. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026